Tarsons Products Stock Hits All-Time Low Amid Prolonged Downtrend

On 19 Nov 2025, Tarsons Products' stock recorded a significant drop, touching an intraday low of Rs 225, marking a fall of 2.51% during the trading session. The stock closed at a level just 0.31% above its 52-week low of Rs 224.3, underscoring the depth of the current downtrend. This movement comes amid a day change of -2.84%, contrasting with the Sensex's modest gain of 0.30% on the same day.

Over the past 13 consecutive trading days, Tarsons Products has experienced a cumulative decline of 22.36%, a stark contrast to the broader market's performance. The stock has underperformed its sector by 2.07% on the day, and its price currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward momentum.

Examining the stock’s performance over various time frames reveals a consistent pattern of underperformance. Over the last one year, Tarsons Products has delivered a return of -43.71%, while the Sensex has recorded a positive return of 9.47%. Year-to-date figures show a similar trend, with the stock down 44.55% against the Sensex’s 8.69% gain. The disparity extends further back, with the stock posting a negative 67.70% return over three years, compared to the Sensex’s 37.73% growth. Notably, the stock has not registered any gains over the past five and ten years, remaining flat, while the Sensex has advanced by 94.79% and 228.64% respectively during these periods.

Financial metrics provide further insight into the challenges faced by Tarsons Products. The company’s operating profit has declined at an annual rate of 18.84% over the last five years, indicating a contraction in core profitability. The latest quarterly results for September 2025 show a Profit After Tax (PAT) of Rs 3.32 crores, which is 51.8% lower than the average of the previous four quarters. This decline in profitability is accompanied by a Return on Capital Employed (ROCE) of 6.69% for the half-year period, which is the lowest recorded level for the company.

Debt metrics reveal a Debt-Equity ratio of 0.41 times for the half-year, the highest in recent periods, suggesting a relatively increased leverage position. Despite this, the company maintains a strong ability to service its debt, with an average EBIT to Interest ratio of 12.03, indicating sufficient earnings to cover interest obligations comfortably.

Valuation indicators highlight that Tarsons Products carries an Enterprise Value to Capital Employed ratio of 1.6, which is considered expensive relative to its current ROCE of 3.9%. However, the stock is trading at a discount compared to the average historical valuations of its peers in the Healthcare Services sector.

Institutional investor participation has also shifted, with a reduction of 3.27% in their stake over the previous quarter. Currently, institutional investors hold 5.91% of the company’s shares. This decline in institutional holding may reflect a reassessment of the company’s fundamentals by investors with greater analytical resources.

Over the last three years, Tarsons Products has consistently underperformed the BSE500 index in each annual period, reinforcing the trend of relative weakness. The stock’s Mojo Score currently stands at 23.0, with a Mojo Grade classified as Strong Sell as of 11 Aug 2025, reflecting an adjustment in evaluation based on recent performance and financial data.

Market capitalisation metrics assign the company a Market Cap Grade of 3, indicating a modest size relative to other listed entities in the sector. The stock’s recent price movements and financial indicators suggest a period of significant adjustment for Tarsons Products within the Healthcare Services industry.

In summary, Tarsons Products has experienced a marked decline in its stock price, reaching an all-time low amid a prolonged period of underperformance against market benchmarks and sector peers. The company’s financial data over recent quarters and years reflect pressures on profitability and valuation, alongside shifts in institutional ownership. While the company maintains a capacity to service its debt, the overall market context for the stock remains subdued.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →